KRISTOFER MCALLISTER: Open Payments
NPI 1972567725 · GRESHAM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 18 payments from 9 companies in 2025. Trend: 2023 $1,429 · 2024 $1,300 · 2025 $433
Food & beverage: $364Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $132 |
| Janssen Biotech, Inc. | 2 | $90 |
| UCB, Inc. | 3 | $71 |
| McKesson Medical-Surgical, Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Lilly USA, LLC | 1 | $23 |
| Amgen Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| GENZYME CORPORATION | 1 | $14 |
Products named: SKYRIZI, TREMFYA, Bimzelx, DUPIXENT, COSENTYX, EBGLYSS, Otezla.
Industry payments across OR — which companies pay providers there.
